Analysing Sepsis Management Part I: Diagnosis

Analysing Sepsis Management Part I: Diagnosis

Recent Advances in Sepsis Diagnosis: PCR, Immunoassays, Sequencing and beyond

RELEASE DATE
22-Jun-2020
REGION
North America
Research Code: D995-01-00-00-00
SKU: HC03306-NA-TR_24516

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC03306-NA-TR_24516

$4,950.00

$3,712.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

Sepsis diagnosis

The current research study discusses the understanding of sepsis, its epidemiology, sepsis diagnosis and unmet clinical need of rapid sepsis diagnosis, existing and developing diagnostic platforms for sepsis management including patents landscape, clinical studies, Regional analysis, companies and their sepsis diagnostic platforms. 

The clinical studies part covers major sepsis diagnosis clinical trials from clinicaltrials.gov, their progress status, type of phase and industrial and non-industrial sponsors.

The sepsis diagnosis platforms discussed in this research study include existing and developing sepsis diagnostic platforms such as procalcitonin immunoassays, lateral flow immunoassays, Heparin Binding Protein (HBP) immunoassays, Complement C5a based immunoassays; nucleic acid sequencing directly from body fluids and identification of pathogens and/or antimicrobial profiling through Artificial Intelligence (AI) based technology; Novel technologies like blood cleaning system, Cell Mechanics, FISH (Fluorescence In-Situ Hybridization), Host-gene-expression-based approaches for sepsis diagnosis. 

A major part of the study talks about a variety of PCR and real-time PCR-based rapid diagnosis platforms for sepsis management. Some of these are direct sample-in/results-out and some platforms require few hours of blood incubation followed by sample-in/results-out. 

Additionally, this study discusses some of the instruments/ analysers and handheld devices, Mass-spectroscopy based sepsis diagnosis, Machine Learning and predictive algorithm for sepsis diagnosis and combination approaches. 

Further, this study profiles major players in sepsis diagnosis from North America, Europe and some players from Asia.

RESEARCH: INFOGRAPHIC

This infographic presents a brief overview of the research, and highlights the key topics discussed in it.
Click image to view it in full size

Table of Contents

1.1 Research Scope: Sepsis Diagnosis

1.2 Analysis Framework: Frost & Sullivan Core Value

1.3 Research Methodology: Five Steps Toward Success

1.4 Key Findings of Technology Breakthrough Driving Sepsis Diagnosis

2.1 Research Scope: Current Status and Challenges of Sepsis Diagnosis

2.2 Types of Sepsis Diagnosis Tests

3.1 Fundamentals and Epidemiology of Sepsis

3.2 Unmet Needs in Sepsis Management

4.1 Outlook of Sepsis Diagnosis Clinical Trials

4.2 Industry Sponsored Sepsis-Diagnostic Test Clinical Trials

4.3 Non-industry Sponsored Sepsis-Diagnostic Test Clinical Trials in Europe

4.4 Non-industry Sponsored Sepsis-Diagnostic Test Clinical Trials in the Americas, Asia and Rest of the World

4.5 Scholarly Publications Including Patents for Sepsis

5.1 List of COMPANIES in Sepsis Diagnosis

5.2 The US Is The Biggest Hub For Sepsis Diagnosis

5.3 Procalcitonin-based Sepsis Diagnosis

5.4 Procalcitonin and Combination-based Sepsis Diagnosis Technologies

5.5 Sepsis Diagnosis Through Multiple Novel Immunoassays

5.6 Sequencing-based Detection of Sepsis Causing Pathogens

5.7 AI-Sequencing Platforms for Sepsis Causing Pathogen Detection

5.8 Machine Learning AND Host gene expression-based Platforms for sepsis diagnosis

5.9 Mass Spectroscopy-based Sepsis Diagnosis Platforms

5.10 Novel Platforms for Sepsis Diagnosis

5.11 Analyzers and Devices for Sepsis Diagnosis

5.12 Europe: PCR-based Sepsis Diagnosis Platforms

5.13 Americas: PCR-based Sepsis Diagnosis Platforms from big Companies

5.14 Americas: PCR-based Sepsis Diagnosis Platforms from mid-sized Companies

5.15 Americas: PCR-based Sepsis Diagnosis Platforms from small Companies

5.16 Asia: PCR-based Sepsis Diagnosis Platforms

5.17 Sepsis Diagnosis Tests under Development

5.18 Sepsis Diagnosis Companies with Revenue

6.1 Growth Opportunity 1: Selecting the Perfect Test for Specific Need

6.2 Growth Opportunity 2: Business Opportunities Beyond Diagnosis

7.1 Industry Interactions

Legal Disclaimer

Related Research
Sepsis diagnosis The current research study discusses the understanding of sepsis, its epidemiology, sepsis diagnosis and unmet clinical need of rapid sepsis diagnosis, existing and developing diagnostic platforms for sepsis management including patents landscape, clinical studies, Regional analysis, companies and their sepsis diagnostic platforms.  The clinical studies part covers major sepsis diagnosis clinical trials from clinicaltrials.gov, their progress status, type of phase and industrial and non-industrial sponsors. The sepsis diagnosis platforms discussed in this research study include existing and developing sepsis diagnostic platforms such as procalcitonin immunoassays, lateral flow immunoassays, Heparin Binding Protein (HBP) immunoassays, Complement C5a based immunoassays; nucleic acid sequencing directly from body fluids and identification of pathogens and/or antimicrobial profiling through Artificial Intelligence (AI) based technology; Novel technologies like blood cleaning system, Cell Mechanics, FISH (Fluorescence In-Situ Hybridization), Host-gene-expression-based approaches for sepsis diagnosis.  A major part of the study talks about a variety of PCR and real-time PCR-based rapid diagnosis platforms for sepsis management. Some of these are direct sample-in/results-out and some platforms require few hours of blood incubation followed by sample-in/results-out.  Additionally, this study discusses some of the instruments/ analysers and handheld devices, Mass-spectroscopy based sepsis diagnosis, Machine Learning and predictive algorithm for sepsis diagnosis and combination approaches.  Further, this study profiles major players in sepsis diagnosis from North America, Europe and some players from Asia.
More Information
No Index No
Podcast No
Author Harshal Patil
Industries Healthcare
WIP Number D995-01-00-00-00
Is Prebook No